International Immunology Advance Access published online on March 28, 2008
International Immunology, doi:10.1093/intimm/dxn031
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Regulatory role of B-1 B cells in chronic colitis
1 Experimental Pathology, Massachusetts General Hospital, Boston, MA 02114, USA
2 Department of Pathology, Harvard Medical School, Boston, MA 02114, USA
3 Gastroenterology Unit, Massachusetts General Hospital, Boston, MA 02114, USA
4 Japan Collection of Microorganisms, RIKEN BioResource Center, Wako, Saitama 310198, Japan
Correspondence to: Correspondence to: A. K. Bhan; E-mail: abhan{at}partners.org
According to the hygiene hypothesis, enhanced microbial exposure due to early childhood infections leads to a reduction of Th2-mediated allergic diseases and inflammatory bowel disease. To begin to elucidate the mechanisms underlying this hypothesis, we studied development of Th2-mediated colitis of the TCR
knockout (KO) mouse in both a specific pathogen-free (SPF) facility and a conventional (CV) facility. After more than five generations in each facility, TCR
KO mice kept in the CV facility developed dramatically less colitis than mice that were kept in the SPF facility. Surprisingly, the suppression of colitis in the CV facility correlated with a significant increase in natural IgM production by B-1 B cells. In contrast, B cell-deficient TCR
double-knockout (
µ DKO) mice maintained in the CV facility continued to develop severe colitis, strongly suggesting that B-1 B cells contributed to the suppression of colitis. Indeed, the adoptive transfer of B-1 B cells isolated from the peritoneal cavity of TCR
KO mice (SPF) into
µ DKO mice (CV) suppressed the development of colitis in the recipient mice. We conclude that B-1 cells play a regulatory role in Th2-mediated colitis under non-hygienic conditions, possibly by generating natural antibodies in response to microbial flora.
Keywords: B-1 B cells, hygiene hypothesis, IBD, KO mice, regulatory B cells, TCR
Transmitting editor: C. Terhorst
Received 19 November 2007, accepted 26 February 2008.